EcoDrugPlus

5-Hydroxytryptamine Receptor 7

Ensembl ID : ENSIPUG00000003823
Gene Symbol: HTR7
3 Cross references
153 Possible Orthologues:

A Disintegrin And Metalloproteinase With Thrombospondin Motifs 5

Ensembl ID : ENSIPUG00000009603
Gene Symbol: LOC108259052
3 Cross references
199 Possible Orthologues:

A-Raf Proto-Oncogene, Serine/threonine Kinase

Ensembl ID : ENSIPUG00000000416
Gene Symbol: ARAF
1 Cross references
184 Possible Orthologues:

A-Raf Proto-Oncogene, Serine/threonine Kinase

Ensembl ID : ENSIPUG00000021951
Gene Symbol: ARAF
3 Cross references
187 Possible Orthologues:

Adam Metallopeptidase Domain 17

Ensembl ID : ENSIPUG00000023507
Gene Symbol: ADAM17
4 Cross references
210 Possible Orthologues:

Adam Metallopeptidase Domain 17a

Ensembl ID : ENSIPUG00000023481
Gene Symbol: ADAM17A
4 Cross references
208 Possible Orthologues:

Adrm1 26s Proteasome Ubiquitin Receptor

Ensembl ID : ENSIPUG00000005765
Gene Symbol: ADRM1
3 Cross references
194 Possible Orthologues:

Adrm1 26s Proteasome Ubiquitin Receptor

Ensembl ID : ENSIPUG00000021877
Gene Symbol: ADRM1
4 Cross references
191 Possible Orthologues:

Apex Nuclease (Multifunctional Dna Repair Enzyme) 1

Ensembl ID : ENSIPUG00000005799
Gene Symbol: APEX1
3 Cross references
212 Possible Orthologues:

Aph1b Gamma Secretase Subunit

Ensembl ID : ENSIPUG00000004792
Gene Symbol: APH1B
4 Cross references
184 Possible Orthologues:

Atp Binding Cassette Subfamily C Member 1

Ensembl ID : ENSIPUG00000011260
Gene Symbol: ABCC1
2 Cross references
201 Possible Orthologues:

Atp Binding Cassette Subfamily C Member 8

Ensembl ID : ENSIPUG00000011235
Gene Symbol: ABCC8
2 Cross references
166 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).